Home › Trial NCT01858649
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
- Trial IDNCT01858649
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain
- Enrollment60
- Start date2013-05
- ConditionsMetastatic Colorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.